Ocean Sciences Ltd
AASX:OSS0.02
AUD
+0.00
(+6.67%)
Ocean Sciences Ltd
ASX:OSS
(Australian Securities Exchange)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Ocean Sciences Ltd (formerly BPH Global Ltd) is an Australian biotechnology and marine resources company specializing in the research, cultivation, processing, commercialization, and trading of seaweed and plant-based botanical extracts. Founded in 1984 and headquartered in Melbourne, Australia, the company operates across the Asia-Pacific region, maintaining corporate, research, and supply chain presences in Australia, Indonesia, Singapore, and China. The company operates across three core business segments: Commercial Seaweed Trading, Marine Biotechnology & Functional Ingredients, and Botanical Extract Solutions. Its product and service portfolio includes: bulk raw and dried commercial seaweed varieties, including Eucheuma cottonii and Gracilaria, supplied for hydrocolloid, food processing, and industrial applications; value-added functional food and beverage ingredients, featuring proprietary freeze-dried, powdered green seaweed water kefir formulations; high-purity bioactive marine extracts and fucoidan-based compounds developed for nutraceutical, anti-aging, pharmaceutical, and cosmeceutical formulations; plant stem cell extracts and botanical derivatives, including Dendrobium orchid-based compounds; organic agricultural inputs, such as seaweed-based bio-stimulants and plant fertilizers; and exploratory marine biotechnology services investigating seaweed bio-accumulation for mineral extraction and blue carbon environmental initiatives. Ocean Sciences Ltd distributes its products to food and beverage manufacturers, health and dietary supplement companies, cosmetics formulators, and industrial agricultural enterprises. The group operates through several key regional subsidiaries, including Stemcell United Pte Ltd in Singapore, PT BPH Global Indonesia in Indonesia, and Hainan SCU Biotechnology Co., Ltd. in China. In September 2026, the company completed a major strategic reorganization, officially changing its name from BPH Global Ltd to Ocean Sciences Ltd, updating its Australian Securities Exchange ticker symbol from BP8 to OSS, and executing a 1-for-10 share capital consolidation to reflect its focus on marine biotechnology and blue economy initiatives. Recent operational and commercial developments include the expansion of its Indonesian seaweed sourcing and trading hubs across South Sulawesi to scale bulk export volumes into mainland China and regional markets; a strategic research and commercialization partnership with Singapore Polytechnic's Food Innovation & Resource Centre (FIRC) to develop scalable powdered green seaweed probiotic kefir ingredients; and an ongoing research collaboration with Indonesia's National Research and Innovation Agency (BRIN) to formulate fucoidan-based bioactive health supplements and anti-aging products.